Trailing-twelve-month (TTM) revenue is $3.33 Billion with a year-over-year growth of +3.19%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $807,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $823,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-28 | $811,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-27 | $883,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $3,326,100,000 |
Current P/S: $20,537,175,000 market capitalization ÷ $3,326,100,000 TTM revenue = 6.17x.
Market capitalization source: FMP quote. Quote observed 2026-09-17T20:00:01.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-27): $883.20M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-18T00:15:39.145Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Advanced Materials Handling AMH | $539M | $705M | $846M | $759M | N/A | N/A |
| Advanced Purity Solutions | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| China | N/A | N/A | $502M | $567M | $671M | N/A |
| CHINA | $118M | $149M | N/A |
$3.33B
$3.33 Billion
+3.19%
vs. $3.22B a year ago (TTM)
+10.64%
5 Year compound annual growth rate
1 Year
+3.19%
3 Year
(2.03%)
5 Year
+10.64%
10 Year
+11.57%
15 Year
+10.46%
20 Year
+9.29%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.20B | ($44.61M) | (1.38%) |
| 2024 | $3.24B | ($282.72M) | (8.02%) |
| 2023 | $3.52B | +$241.89M | +7.37% |
| 2022 | $3.28B | +$983.14M | +42.77% |
| 2021 | $2.30B | +$439.58M | +23.64% |
| 2020 |
TTM Growth
+3.19%
3-Year CAGR
(2.03%)
5-Year CAGR
+10.64%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-18T00:15:39.145Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $607M |
| N/A |
| $1.9B |
| $1.8B |
| intersegment sales elimination | -$31M | -$37M | -$51M | -$52M | -$9M | N/A |
|---|
| Materials Solutions MS | N/A | N/A | N/A | $1.7B | $1.4B | $1.4B |
|---|
| Microcontamination Control MC | $742M | $919M | $1.1B | $1.1B | N/A | N/A |
|---|
| Specialty Chemicals and Electronic Materials SCEM | $610M | $711M | $774M | N/A | N/A | N/A |
|---|
| N/A |
| $658M |
| Europe | $106M | $120M | $325M | $402M | $275M | $239M |
|---|
| Japan | N/A | N/A | $350M | $367M | $309M | N/A |
|---|
| JAPAN | $156M | $169M | N/A | N/A | N/A | $318M |
|---|
| KOREA, REPUBLIC OF | $146M | $217M | N/A | N/A | N/A | $429M |
|---|
| North America | N/A | N/A | $796M | $891M | $672M | N/A |
|---|
| SINGAPORE | $65M | N/A | N/A | N/A | N/A | N/A |
|---|
| South Korea | N/A | N/A | $414M | $443M | $419M | N/A |
|---|
| Southeast Asia | N/A | $111M | $235M | $262M | $232M | $256M |
|---|
| Taiwan | N/A | N/A | $660M | $591M | $663M | N/A |
|---|
| TAIWAN, PROVINCE OF CHINA | $291M | $290M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $254M | $286M | N/A | N/A | N/A | N/A |
|---|
| $1.86B |
| +$268.25M |
| +16.86% |
| 2019 | $1.59B | +$40.57M | +2.62% |
| 2018 | $1.55B | +$207.97M | +15.49% |
| 2017 | $1.34B | +$167.26M | +14.23% |
| 2016 | $1.18B | +$94.15M | +8.71% |
